This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Diller, G.-P. Articles by Gatzoulis, M. A. Search for Related Content PubMed PubMed Citation Articles by Diller, G.-P. Articles by Gatzoulis, M. A. Pubmed/NCBI databases Medline Plus Health Information Congenital Heart Defects Pulmonary Hypertension Related Collections Pulmonary biology and circulation Pediatric and congenital heart disease, including cardiovascular surgery

(Circulation. 2007;115:1039-1050.)
© 2007 American Heart Association, Inc.

Congenital Heart Disease for the Adult Cardiologist

Pulmonary Vascular Disease in Adults With Congenital Heart Disease

Gerhard-Paul Diller, MD; Michael A. Gatzoulis, MD, PhD

From the Adult Congenital Heart Center and Center for Pulmonary Hypertension, Royal Brompton Hospital, and the National Heart and Lung Institute, Imperial College, London, UK.

Correspondence to Michael A. Gatzoulis, MD, PhD, Royal Brompton Hospital, Sydney St, London, SW3 6NP, UK. E-mail m.gatzoulis{at}rbh.nthames.nhs.uk

Pulmonary arterial hypertension of variable degree is commonly associated with adult congenital heart disease. Depending on size and location of the underlying cardiac defect as well as on repair status, pulmonary arterial hypertension may present with or without reversed shunting and associated cyanosis (ie, Eisenmenger syndrome). We review available data on etiology, clinical presentation, prognosis, and management strategies of pulmonary arterial hypertension in adult patients with congenital heart disease. In addition, we discuss the numerous complications associated with Eisenmenger syndrome, representing a multisystem disorder. Finally, we present general management strategies and emerging disease-targeting therapies.

Key Words: heart defects, congenital • hypertension, pulmonary • pulmonary vascular disease

This article has been cited by other articles:

				T. G. Smith, N. P. Talbot, C. Privat, M. Rivera-Ch, A. H. Nickol, P. J. Ratcliffe, K. L. Dorrington, F. Leon-Velarde, and P. A. Robbins Effects of Iron Supplementation and Depletion on Hypoxic Pulmonary Hypertension: Two Randomized Controlled Trials JAMA, October 7, 2009; 302(13): 1444 - 1450. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members, N. Galie, M. M. Hoeper, M. Humbert, A. Torbicki, J.-L. Vachiery, J. A. Barbera, M. Beghetti, P. Corris, S. Gaine, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur. Heart J., October 2, 2009; 30(20): 2493 - 2537. [Full Text] [PDF]

				G. Yong, P. Khairy, P. De Guise, A. Dore, F. Marcotte, L.-A. Mercier, S. Noble, and R. Ibrahim Pulmonary Arterial Hypertension in Patients With Transcatheter Closure of Secundum Atrial Septal Defects: A Longitudinal Study Circ Cardiovasc Interv, October 1, 2009; 2(5): 455 - 462. [Abstract] [Full Text] [PDF]

				M. A. Gatzoulis, R. Alonso-Gonzalez, and M. Beghetti Pulmonary arterial hypertension in paediatric and adult patients with congenital heart disease Eur. Respir. Rev., September 1, 2009; 18(113): 154 - 161. [Abstract] [Full Text] [PDF]

				C. D. Vizza, R. Badagliacca, R. Poscia, C. Gambardella, B. Pezzuto, E. Crescenzi, S. Papa, and F. Fedele Unusual presentation for a patent ductus arteriosus Eur. Respir. Rev., September 1, 2009; 18(113): 174 - 176. [Abstract] [Full Text] [PDF]

				M. Beghetti and N. Galie Eisenmenger syndrome a clinical perspective in a new therapeutic era of pulmonary arterial hypertension. J. Am. Coll. Cardiol., March 3, 2009; 53(9): 733 - 740. [Abstract] [Full Text] [PDF]

				E. Bedard, K. Dimopoulos, and M. A. Gatzoulis Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension? Eur. Heart J., February 1, 2009; 30(3): 256 - 265. [Abstract] [Full Text] [PDF]

				D. M. Smadja, P. Gaussem, L. Mauge, D. Israel-Biet, F. Dignat-George, S. Peyrard, G. Agnoletti, P. R. Vouhe, D. Bonnet, and M. Levy Circulating Endothelial Cells: A New Candidate Biomarker of Irreversible Pulmonary Hypertension Secondary to Congenital Heart Disease Circulation, January 27, 2009; 119(3): 374 - 381. [Abstract] [Full Text] [PDF]

				G.-P. Diller, S. van Eijl, D. O. Okonko, L. S. Howard, O. Ali, T. Thum, S. J. Wort, E. Bedard, J. S. R. Gibbs, J. Bauersachs, et al. Circulating Endothelial Progenitor Cells in Patients With Eisenmenger Syndrome and Idiopathic Pulmonary Arterial Hypertension Circulation, June 10, 2008; 117(23): 3020 - 3030. [Abstract] [Full Text] [PDF]

				E. Bedard, D. F. Shore, and M. A. Gatzoulis Adult congenital heart disease: a 2008 overview Br. Med. Bull., March 1, 2008; 85(1): 151 - 180. [Abstract] [Full Text] [PDF]